Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Completed 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Rectal Neoplasms 1Neurologic Manifestations 1Neuralgia 1Depression 1Cognitive Dysfunction 1Brain Neoplasms 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Transcranial Magnetic Stimulation × Clear all
NCT07187219 2025-09-22

NeuroCanPain

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Recruiting
60 enrolled

Neoplasms, Neuralgia

NCT06589544 2024-09-19

INCEPT

University Hospital of Ferrara

Phase NA Recruiting
100 enrolled

Depression, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡